» Articles » PMID: 25884481

The Non-coding RNAs of the H19-IGF2 Imprinted Loci: a Focus on Biological Roles and Therapeutic Potential in Lung Cancer

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2015 Apr 18
PMID 25884481
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Since it was first described, the imprinted cluster 11p15.5 has been reported to be deregulated in a variety of pediatric and adult cancers including that of the lung. Both protein coding and non-coding genes functioning as oncogenes or as tumor suppressor genes reside within this cluster. Oncomirs that can function as oncogenes or as tumor suppressors have also been reported. While a complete account of the role played by the 11p15.5 imprinted cluster in lung cancer is beyond the scope of this review, we will focus on the role of the non-coding RNAs processed from the H19-IGF2 loci. A special emphasis will be given to the H19/miR-675 gene locus. Their potential diagnostic and therapeutic use in lung cancer will be described.

Citing Articles

Long non-coding RNA H19 as a prognostic biomarker for oral squamous cell carcinoma.

Kumar K, Hallikeri K, Oli A, Radder K, Jain A, Shilpasree A Front Med (Lausanne). 2024; 11:1456963.

PMID: 39659621 PMC: 11628285. DOI: 10.3389/fmed.2024.1456963.


Structural Modifications and Novel Protein-Binding Sites in Pre-miR-675-Explaining Its Regulatory Mechanism in Carcinogenesis.

Dey A Noncoding RNA. 2023; 9(4).

PMID: 37624037 PMC: 10457854. DOI: 10.3390/ncrna9040045.


Epigenetic Reprogramming in and : From Fertilization to Primordial Germ Cell Development.

Singh A, Rappolee D, Ruden D Cells. 2023; 12(14).

PMID: 37508536 PMC: 10377882. DOI: 10.3390/cells12141874.


Long noncoding RNA (lncRNA) : An essential developmental regulator with expanding roles in cancer, stem cell differentiation, and metabolic diseases.

Liao J, Chen B, Zhu Z, Du C, Gao S, Zhao G Genes Dis. 2023; 10(4):1351-1366.

PMID: 37397543 PMC: 10311118. DOI: 10.1016/j.gendis.2023.02.008.


Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer.

Boyero L, Noguera-Ucles J, Castillo-Pena A, Salinas A, Sanchez-Gastaldo A, Alonso M Cancers (Basel). 2023; 15(5).

PMID: 36900258 PMC: 10000578. DOI: 10.3390/cancers15051466.


References
1.
Lima A, Macedo L, Sasse A . Addition of bevacizumab to chemotherapy in advanced non-small cell lung cancer: a systematic review and meta-analysis. PLoS One. 2011; 6(8):e22681. PMC: 3149053. DOI: 10.1371/journal.pone.0022681. View

2.
Li Y, Zhang Y, Wang P, Chi Y, Zhang C, Ma Y . Regression of A549 lung cancer tumors by anti-miR-150 vector. Oncol Rep. 2011; 27(1):129-34. DOI: 10.3892/or.2011.1466. View

3.
Calin G, Croce C . MicroRNA-cancer connection: the beginning of a new tale. Cancer Res. 2006; 66(15):7390-4. DOI: 10.1158/0008-5472.CAN-06-0800. View

4.
Keniry A, Oxley D, Monnier P, Kyba M, Dandolo L, Smits G . The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r. Nat Cell Biol. 2012; 14(7):659-65. PMC: 3389517. DOI: 10.1038/ncb2521. View

5.
Ortholan C, Puissegur M, Ilie M, Barbry P, Mari B, Hofman P . MicroRNAs and lung cancer: new oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targets. Curr Med Chem. 2009; 16(9):1047-61. DOI: 10.2174/092986709787581833. View